Inhibition of inflammation mediates the protective effect of atorvastatin reload in patients with coronary artery disease undergoing noncardiac emergency surgery. [electronic resource]
Producer: 20160509Description: 678-84 p. digitalISSN:- 1473-5830
- Acute Disease
- Aged
- Anti-Inflammatory Agents -- administration & dosage
- Atorvastatin -- administration & dosage
- Biomarkers -- blood
- C-Reactive Protein -- metabolism
- Chi-Square Distribution
- China -- epidemiology
- Coronary Artery Disease -- complications
- Disease-Free Survival
- Drug Administration Schedule
- Emergencies
- Female
- Heart Failure -- diagnosis
- Hospitalization
- Humans
- Incidence
- Inflammation Mediators -- blood
- Interleukin-6 -- blood
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Prospective Studies
- Risk Factors
- Single-Blind Method
- Surgical Procedures, Operative -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.